These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12938144)

  • 1. Serum cystatin C may predict the early prognostic stages of patients with type 2 diabetic nephropathy.
    Shimizu A; Horikoshi S; Rinnno H; Kobata M; Saito K; Tomino Y
    J Clin Lab Anal; 2003; 17(5):164-7. PubMed ID: 12938144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-trace protein, a new marker of GFR, may predict the early prognostic stages of patients with type 2 diabetic nephropathy.
    Kobata M; Shimizu A; Rinno H; Hamada C; Maeda K; Fukui M; Saito K; Horikoshi S; Tomino Y
    J Clin Lab Anal; 2004; 18(4):237-9. PubMed ID: 15202116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is serum cystatin C an accurate endogenous marker of glomerular filteration rate for detection of early renal impairment in patients with type 2 diabetes mellitus?
    El-Shafey EM; El-Nagar GF; Selim MF; El-Sorogy HA; Sabry AA
    Ren Fail; 2009; 31(5):355-9. PubMed ID: 19839834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine.
    Shimizu-Tokiwa A; Kobata M; Io H; Kobayashi N; Shou I; Funabiki K; Fukui M; Horikoshi S; Shirato I; Saito K; Tomino Y
    Nephron; 2002 Sep; 92(1):224-6. PubMed ID: 12187109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
    Oddoze C; Morange S; Portugal H; Berland Y; Dussol B
    Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cystatin C may predict the prognostic stages of patients with IgA nephropathy prior to renal biopsy.
    Tomino Y; Suzuki S; Gohda T; Kobayashi M; Horikoshi S; Imai H; Saito T; Kawamura T; Yorioka N; Harada T; Yasumoto Y; Kida H; Kobayashi Y; Endoh M; Sato H; Saito K
    J Clin Lab Anal; 2001; 15(1):25-9. PubMed ID: 11170230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cystatin C advantageous compared with serum creatinine in the detection of mild but not severe diabetic nephropathy.
    Christensson AG; Grubb AO; Nilsson JA; Norrgren K; Sterner G; Sundkvist G
    J Intern Med; 2004 Dec; 256(6):510-8. PubMed ID: 15554952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy.
    Lee BW; Ihm SH; Choi MG; Yoo HJ
    Diabetes Res Clin Pract; 2007 Dec; 78(3):428-34. PubMed ID: 17822797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cystatin C assay for the detection of early renal impairment in diabetic patients.
    Xia LH; Bing XG; An XT
    J Clin Lab Anal; 2004; 18(1):31-5. PubMed ID: 14730555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serum cystatin C and chromogranin A as markers of nephropathy in patients with type 2 diabetes mellitus.
    Mojiminiyi OA; Abdella N; George S
    Scand J Clin Lab Invest; 2000 Oct; 60(6):483-9. PubMed ID: 11129064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
    Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
    Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cystatin C, enzymuria, tubular proteinuria and early renal insult in type 2 diabetes.
    Kalansooriya A; Holbrook I; Jennings P; Whiting PH
    Br J Biomed Sci; 2007; 64(3):121-3. PubMed ID: 17910281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystatin C as an early marker of diabetic nephropathy in patients with type 2 diabetes.
    Jeon YL; Kim MH; Lee WI; Kang SY
    Clin Lab; 2013; 59(11-12):1221-9. PubMed ID: 24409655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients.
    Mussap M; Dalla Vestra M; Fioretto P; Saller A; Varagnolo M; Nosadini R; Plebani M
    Kidney Int; 2002 Apr; 61(4):1453-61. PubMed ID: 11918752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing the GFR estimation equations using both creatinine and cystatin c to predict the long-term renal outcome in type 2 diabetic nephropathy patients.
    Pan Y; Jiang S; Qiu D; Shi J; Zhou M; An Y; Ge Y; Xie H; Liu Z
    J Diabetes Complications; 2016; 30(8):1478-1487. PubMed ID: 27593903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asian multicenter trials on urinary type IV collagen in patients with diabetic nephropathy.
    Tomino Y; Suzuki S; Azushima C; Shou I; Iijima T; Yagame M; Wang LN; Chen HC; Lai KN; Tan SY; Kim MJ
    J Clin Lab Anal; 2001; 15(4):188-92. PubMed ID: 11436201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystatin C as a marker for detection of early renal failure in diabetes type 2 patients.
    Ascić-Buturović B; Cavaljuga S
    Bosn J Basic Med Sci; 2005 Nov; 5(4):68-71. PubMed ID: 16351602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interest of cystatin C in screening diabetic patients for early impairment of renal function.
    Perlemoine C; Beauvieux MC; Rigalleau V; Baillet L; Barthes N; Derache P; Gin H
    Metabolism; 2003 Oct; 52(10):1258-64. PubMed ID: 14564676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth arrest-specific protein 6 (Gas6) as a noninvasive biomarker for early detection of diabetic nephropathy.
    Li W; Wang J; Ge L; Shan J; Zhang C; Liu J
    Clin Exp Hypertens; 2017; 39(4):382-387. PubMed ID: 28513288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystatin-C and TGF-β levels in patients with diabetic nephropathy.
    Takir M; Unal AD; Kostek O; Bayraktar N; Demirag NG
    Nefrologia; 2016; 36(6):653-659. PubMed ID: 27745866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.